Pharmacy procedures, page 5 of 5

Progestin modifying agent therapy

progestin modifying agent therapy: Treatment with an agent to modify progestin action.

As a treatment, progestin modifying agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• progestin modifying drug treatment
• treatment with progestin modifier
• treatment with progestin modifying agent
• treatment with progestin modifying drug
• treatment with progestin modifying medication

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000288 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › hormone modifying therapy › sex hormone modifying agent therapy › menopausal hormone therapy.

Specialty: Pharmacy

Broader services

• menopausal hormone therapy

Used to treat

• multiple endocrine neoplasia type 2A
• tongue squamous cell carcinoma
• retinitis pigmentosa 42
• autosomal dominant nonsyndromic deafness 33
• xeroderma pigmentosum group F

Showing 5 of 11.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before progestin modifying agent therapy.

Available at

• Longview Woodland Health Center

Providers offering this service

• Dr. Paula Ho, MD
• Dr. Imani Hamilton, MD
• Dr. Aisha Morgan, MD
• Dr. Liam Kelly, DO
• Dr. Nathan Wagner, MD

Showing 5 of 13.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000288

Receptor antagonist therapy

Use of a substance that attaches to and blocks cell receptors. Our Pharmacy team performs receptor antagonist therapy and explains each step beforehand.

As a treatment, receptor antagonist therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• treatment with antagonist

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000161 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › molecular pathway modifying agent therapy.

Specialty: Pharmacy

Broader services

• molecular pathway modifying agent therapy

More specific services

• parathyroid-suppressant hormone therapy
• androgen suppressant hormone agent therapy
• antihistamine agent therapy
• antileukotriene agent therapy
• angiotensin receptor blocker therapy
• metabotropic glutamate receptor antagonist therapy
• AMPA receptor antagonist therapy

Used to treat

• xanthinuria
• chromosome 5p13 duplication syndrome
• hereditary spastic paraplegia 25
• distal myopathy
• endocardial fibroelastosis

Showing 5 of 11.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Canby Eastside Specialty Clinic
• Lake Oswego Southgate Specialty Clinic
• Tualatin Willow Creek Clinic
• Newberg Willow Creek Family Health Clinic

Providers offering this service

• Dr. Amir Hassan, DO
• Dr. Darius Aguilar, MD
• Dr. Imani Arora, DO
• Laura Reed, NP
• Dr. Zainab Kumar, DO

Showing 5 of 14.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000161
• http://purl.obolibrary.org/obo/NCIT_C69308

Selective-estrogen receptor modifying agent therapy

About this service. Treatment with an agent to that selectively modifies estrogen receptor action.

As a treatment, selective-estrogen receptor modifying agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000289 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › hormone modifying therapy › sex hormone modifying agent therapy.

Specialty: Pharmacy

Broader services

• sex hormone modifying agent therapy

Used to treat

• asphyxiating thoracic dystrophy
• hereditary spastic paraplegia 25
• chromosome 2q37 deletion syndrome
• Bell's palsy
• sweat gland disease

Showing 5 of 10.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Providers offering this service

• Joseph Burke, NP
• Dr. Nora Richards, MD
• Dr. Julia Miller, DO
• Dr. Nadia Dang, MD
• Dr. Darius Banerjee, MD

Showing 5 of 9.

Related articles

• Selective-estrogen receptor modifying agent therapy: Preparing and Recovering

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000289

Serotonin-norepinephrine reuptake inhibitor agent therapy

Treatment with a medication that increases the extracellular level of the neurotransmitter serotonin (5-HT) and norepinephrine by inhibiting their reuptake into the presynaptic cell. Our Pharmacy team performs serotonin-norepinephrine reuptake inhibitor agent therapy and explains each step beforehand.

As a treatment, serotonin-norepinephrine reuptake inhibitor agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• serotonin and noradrenaline reuptake inhibitor agent therapy
• serotonin and noradrenaline reuptake inhibitor drug therapy
• serotonin and noradrenaline reuptake inhibitor drug treatment
• serotonin and norepinephrine reuptake inhibitor therapy
• serotonin-noradrenaline reuptake inhibitor agent therapy
• serotonin-noradrenaline reuptake inhibitor drug treatment
• serotonin-norepinephrine reuptake inhibitor drug treatment
• SNRI agent therapy
• SNRI drug therapy
• SNRI drug treatment

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000214 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › central nervous system agent therapy › psychotropic agent therapy › antidepressant agent therapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

Used to treat

• hypogonadotropic hypogonadism 6 with or without anosmia
• short-rib thoracic dysplasia 6 with or without polydactyly
• Charcot-Marie-Tooth disease type 4G
• cataract 46 juvenile-onset
• long QT syndrome 13

Showing 5 of 15.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Providers offering this service

• Dr. Sana Farah, MD
• Dr. Andre Li, MD
• Dr. Anthony Brown, MD
• Dr. Carlos Murphy, MD
• Dr. Joel Hill, DO

Showing 5 of 9.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000214

Smoking cessation agent therapy

Treatment with a drug that deters smoking or encourages the cessation of smoking tobacco. Our Pharmacy team performs smoking cessation agent therapy and explains each step beforehand.

As a treatment, smoking cessation agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• smoking cessation drug treatment

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0001004 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › therapeutic antidotes, deterrents, and toxicologic agent therapy › abuse deterrent agent therapy.

Specialty: Pharmacy

Broader services

• abuse deterrent agent therapy

Used to treat

• secondary progressive multiple sclerosis
• paroxysmal nocturnal hemoglobinuria
• ZTTK syndrome
• autosomal dominant nonsyndromic deafness 53
• Johanson-Blizzard syndrome

Showing 5 of 10.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Providers offering this service

• Dr. Olivia Morales, MD
• Dr. Jorge Nguyen, MD
• Dr. Andre Turner, DO
• Angela Alvarez, NP
• Dr. Olivia Davis, MD

Showing 5 of 15.

Related articles

• Questions to Ask About Smoking cessation agent therapy

Reference links

• http://purl.obolibrary.org/obo/MAXO_0001004

Sodium channel inhibitor therapy

About this service. Use of a drug that inhibits sodium influx through cell membranes.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• Na+ channel blocker therapy
• Na+ channel inhibitor drug therapy
• sodium channel blocker drug therapy
• sodium channel inhibitor drug therapy
• treatment with Na+ channel inhibitor
• treatment with sodium channel antagonist
• treatment with sodium channel blocker
• treatment with sodium channel inhibitor

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000208 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › central nervous system agent therapy › anticonvulsant agent therapy.

Specialty: Pharmacy

Broader services

• molecular pathway modifying agent therapy
• pharmacotherapy

Used to treat

• mastoiditis
• KRT1-related nonepidermolytic palmoplantar keratoderma
• laryngomalacia
• acute myeloid leukemia without maturation
• retinitis pigmentosa 37

Showing 5 of 11.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Corvallis Valley Clinic
• Portland Westside Clinic
• Tigard Northgate Health Center
• Newberg Willow Creek Family Health Clinic

Providers offering this service

• Dr. Pablo Mitchell, MD
• Dr. Javier Kelly, MD
• Dr. Jessica Obi, MD
• Dr. Ethan Choi, DO
• Dr. Joseph Santos, MD

Showing 5 of 12.

Related articles

• Sodium channel inhibitor therapy: Preparing and Recovering
• What to Expect: Sodium channel inhibitor therapy

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000208

Steroid agent therapy

Treatment with a class of steroid hormones. This page describes steroid agent therapy and where it is available across Weyland-Yutani Health System.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0001575 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › anti-inflammatory agent therapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

More specific services

• corticosteroid agent therapy

Used to treat

• infantile Refsum disease
• Mast syndrome
• autosomal recessive cutis laxa type IIA
• gnathodiaphyseal dysplasia
• louse-borne relapsing fever

Showing 5 of 15.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Available at

• Beaverton Cedar Hills Medical Center

Providers offering this service

• Dr. Darius Brooks, DO
• Dr. Marcus Farah, DO
• Dr. Ivan Morgan, MD
• Dr. Nora Adeyemi, MD
• Dr. Kevin Burke, MD

Showing 5 of 12.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0001575

Sulfonamide antibacterial agent therapy

About this service. Use of a class of sulfonamides whose members generally have bacteriostatic antibiotic properties.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• sulfonamide antibacterial drug therapy
• sulfonamide antibacterial therapy
• sulfonamide antibiotic therapy
• sulfonamide drug therapy
• sulfonamide drug treatment
• treatment with a sulfonamide antibacterial drug
• treatment with a sulfonamide antibacterial medication
• treatment with a sulfonamide antibiotic agent
• treatment with a sulfonamide antibiotic drug
• treatment with a sulfonamide antibiotic medication
• treatment with a sulfonamide antibiotic therapy

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000202 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › anti-infective agent therapy › antimicrobial agent therapy › antibacterial agent therapy.

Specialty: Pharmacy

Broader services

• antibacterial agent therapy
• gastrointestinal agent therapy

Used to treat

• Noonan syndrome 2
• Usher syndrome type 1K
• malignant eyelid melanoma
• Dressler's syndrome

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Forest Grove Maple Park Family Health Clinic

Providers offering this service

• Dr. Ravi Martinez, DO
• Dr. Anika Wong, MD
• Dr. Claire Suzuki, MD
• Dr. Noah Hughes, MD
• Dr. Ravi Adeyemi, MD

Showing 5 of 8.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000202

Sulfonylurea agent therapy

Treatment with sulfonamide urea derivatives with antihyperglycemic activity. Weyland-Yutani Health System offers sulfonylurea agent therapy through Pharmacy.

As a treatment, sulfonylurea agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• sulfonylurea antidiabetic agent therapy
• treatment with sulfonylurea
• treatment with sulfonylurea agent

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000743 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › antidiabetic agent therapy › hypoglycemic drug therapy.

Specialty: Pharmacy

Broader services

• hypoglycemic drug therapy

Used to treat

• Usher syndrome
• hypogonadotropic hypogonadism 5 with or without anosmia
• pentosuria
• tabes dorsalis
• bladder diverticulum

Showing 5 of 11.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Providers offering this service

• Dr. Joel Cohen, MD
• Dr. Andre Turner, DO
• Dr. Aaron Bailey, MD
• Dr. Eli Dang, MD
• Dr. Rebecca Dang, MD

Showing 5 of 9.

Related articles

• Is Sulfonylurea agent therapy Right for You?
• Sulfonylurea agent therapy: Preparing and Recovering

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000743
• http://purl.obolibrary.org/obo/NCIT_C97936

Therapeutic antidotes, deterrents, and toxicologic agent therapy

therapeutic antidotes, deterrents, and toxicologic agent therapy: A grouping of agents that are used as antidotes, deterrents, or to counteract the effects of a toxic agents on the body.

As a treatment, therapeutic antidotes, deterrents, and toxicologic agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000172 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

More specific services

• abuse deterrent agent therapy

Used to treat

• ankyloglossia
• autosomal recessive cutis laxa type I
• Worth syndrome
• short-rib thoracic dysplasia 7 with or without polydactyly
• parotitis

Showing 5 of 10.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Gresham Heritage Specialty Clinic

Providers offering this service

• Dr. Gabriel Burke, MD
• Dr. Isabella Delgado, MD
• Dr. Fatima Gordon, MD
• Dr. Mei Cooper, MD
• Dr. Elijah Edwards, DO

Showing 5 of 12.

Related articles

• Questions to Ask About Therapeutic antidotes, deterrents, and toxicologic agent therapy

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000172

Tocolytic agent therapy

About this service. Use of drug or agent to suppress uterine contractions thereby suppressing premature labor and birth.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• treatment with tocolytic agent

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0010127 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › reproductive control agent therapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

Used to treat

• hydrolethalus syndrome
• pontocerebellar hypoplasia type 6
• ring chromosome 20 syndrome
• hypertension
• middle ear cholesterol granuloma

Showing 5 of 17.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Providers offering this service

• Dr. Sana Farah, MD
• Noah Robinson, NP
• Dr. Victor Hall, MD
• Dr. Claire Adeyemi, DO
• Dr. Anthony Vargas, MD

Showing 5 of 15.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0010127

Topical pharmacotherapy

The use of any drug or chemical treatment applied to the surface of the body. This page describes topical pharmacotherapy and where it is available across Weyland-Yutani Health System.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0001573 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

More specific services

• topical anesthetic therapy
• emollient therapy

Used to treat

• variola major
• hereditary spastic paraplegia 34
• pancytopenia
• transient cerebral ischemia
• salpingitis

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Tualatin Valley Clinic

Providers offering this service

• Dr. Lucas Santos, MD
• Dr. Gabriel Nakamura, DO
• Dr. Bianca Anderson, MD
• Camila Castillo, NP
• Dr. Claire Martin, MD

Showing 5 of 15.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0001573

Vasodilator agent therapy

vasodilator agent therapy: A therapy using a drug to cause dilation of the blood vessels.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• vasodilating agent therapy
• vasodilating drug treatment therapy
• vasodilator drug therapies
• vasodilator drug therapy
• vasodilator drug treatment therapy
• vasodilator therapies

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000191 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › cardiovascular agent therapy.

Specialty: Pharmacy

Broader services

• cardiovascular agent therapy

More specific services

• ACE2 inhibitor therapy

Used to treat

• biliary tract benign neoplasm
• orofaciodigital syndrome V
• endometritis
• dissociative disorder
• acute hemorrhagic leukoencephalitis

Showing 5 of 11.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Providers offering this service

• Dr. Liam Chen, MD
• Dr. Emily Dang, DO
• Joel Gill, NP
• Dr. Maria Reed, MD
• Dr. Fatima Jackson, MD

Showing 5 of 10.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000191
• http://purl.obolibrary.org/obo/NCIT_C29707

Weight loss pharmacotherapy

An agent or drug used to reduce or control weight. Our Pharmacy team performs weight loss pharmacotherapy and explains each step beforehand.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000909 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

Used to treat

• Bardet-Biedl syndrome 15
• ectopia lentis with ectopia of pupil
• diaphragm disease
• mucopolysaccharidosis III
• colon squamous cell carcinoma

Showing 5 of 7.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before weight loss pharmacotherapy.

Available at

• Corvallis Valley Clinic

Providers offering this service

• Jonah Murphy, NP
• Dr. Zainab Bianchi, MD
• Dr. Aaron Roberts, MD
• Dr. Angela Wang, MD
• Dr. Oscar Edwards, MD

Showing 5 of 7.

Related articles

• Weight loss pharmacotherapy: Preparing and Recovering

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000909